Related Experiment Video
Updated: May 17, 2026
06:46
Investigating the Deployment of Visual Attention Before Accurate and Averaging Saccades via Eye Tracking and Assessment of Visual Sensitivity
Published on: March 18, 2019
Cholinergic enhancement reduces orientation-specific surround suppression but not visual crowding
Anna A Kosovicheva1, Summer L Sheremata, Ariel Rokem
1Department of Psychology, University of California, Berkeley Berkeley, CA, USA.
Frontiers in Behavioral Neuroscience
|October 11, 2012
Summary
Cholinergic enhancement reduced orientation-specific surround suppression, indicating acetylcholine impacts spatial interactions in early visual processing. However, it did not affect crowding, suggesting these effects are specific to certain visual tasks.
Area of Science:
- Neuroscience
- Visual Perception
- Cognitive Science
Background:
- Acetylcholine (ACh) is known to modulate neural activity and receptive field sizes in the early visual cortex.
- Spatial interactions, such as surround suppression and crowding, are crucial for visual processing and are thought to involve early visual cortex mechanisms.
Purpose of the Study:
- To investigate the perceptual consequences of increased acetylcholine levels on visual spatial interactions.
- To determine if cholinergic enhancement affects orientation-specific surround suppression (OSSS) and crowding.
Main Methods:
- A placebo-controlled, double-blind study using the cholinesterase inhibitor donepezil to increase synaptic acetylcholine levels in healthy human subjects.
- Experiment 1: Measured contrast discrimination thresholds for a central grating under parallel, orthogonal, or no surround conditions to assess OSSS.
- Experiment 2: Assessed the effect of donepezil on critical spacing in a letter crowding task.
Main Results:
- Cholinergic enhancement significantly reduced OSSS, indicated by lower contrast discrimination thresholds in the parallel surround condition.
- No significant effect of donepezil was observed on the critical spacing required for letter identification in the crowding task.
- These findings suggest acetylcholine differentially affects spatial interactions based on the task demands.
Conclusions:
- Acetylcholine plays a role in modulating spatial interactions within the early visual cortex, specifically reducing orientation-specific surround suppression.
- The lack of effect on crowding suggests that cholinergic modulation of spatial interactions may be limited to specific processing stages or types of visual tasks.
- These results contribute to understanding how acetylcholine influences visual perception and cortical processing.
Related Concept Videos
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:28Cholinergic Antagonists: Pharmacological Actions
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.